Samuel Opoku Asiedu1, Alexander Kwarteng2,3, Emmanuel Kobla Atsu Amewu4, Priscilla Kini1,4, Bill Clinton Aglomasa4, John Boulard Forkuor5. 1. Kumasi Centre for Collaborative Research in Tropical Medicine, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana. 2. Kumasi Centre for Collaborative Research in Tropical Medicine, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana. senkwarteng@yahoo.co.uk. 3. Department of Biochemistry and Biotechnology, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana. senkwarteng@yahoo.co.uk. 4. Department of Biochemistry and Biotechnology, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana. 5. Department of Sociology and Social Work, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.
Abstract
BACKGROUND: Human lymphatic filarial pathology is the leading cause of disability and poverty among people living with the infection. The second goal of the Global Programme to Eliminate Lymphatic Filariasis (GPELF) is to manage the disease's morbidity to improve patients' quality of life. Consequently, the current study assessed the overall quality of life of lymphatic filariasis (LF) pathology patients in some selected endemic communities in rural Ghana. METHOD: In the present study, the Lymphatic Filariasis Quality of Life Questionnaire (LFSQQ) was used to evaluate the effect of lymphatic filariasis on the quality of life of people, with the disease in nine (9) communities in the Ahanta West District of the Western Region of Ghana where mass drug administration is being implemented for the past twenty years. Pearson's correlation, linear regression, and one-way analysis of variance (ANOVA) analyses were used to assess the associations between the LFSQQ instrument domains. RESULTS: Of the 155 study participants recruited, 115 (74.19%) were females, and 40 (25.81%) males. A greater proportion of the study participants (40, 25.8%) were presented with stage two (2) lymphoedema, while only two patients had stage seven (7) lymphoedema. The average of the overall quality of life scores of study participants was 68.24. There was a negative Pearson correlation (r = - 0.504, p-value < 0.001) between the stage of lymphoedema (severity of the disease) and the quality of life of the LF patients. In addition, a clear pattern of positive correlation (r = 0.71, p-value < 0.001) was observed between the disease burden and pain/discomfort domains of the study participants. Whereas the highest domain-specific score (85.03) was observed in the domain of self-care, we noted that the environmental domain, which consists of the financial status, was the lowest (45.94) among the study participants. CONCLUSION: Our findings support previous works on the reduced quality of life among lymphatic filariasis patients with pathology. In this study, our results reveal a depressing financial condition among people presenting with late stages of LF pathologies, which eventually reduces their well-being.
BACKGROUND:Human lymphatic filarial pathology is the leading cause of disability and poverty among people living with the infection. The second goal of the Global Programme to Eliminate Lymphatic Filariasis (GPELF) is to manage the disease's morbidity to improve patients' quality of life. Consequently, the current study assessed the overall quality of life of lymphatic filariasis (LF) pathology patients in some selected endemic communities in rural Ghana. METHOD: In the present study, the Lymphatic Filariasis Quality of Life Questionnaire (LFSQQ) was used to evaluate the effect of lymphatic filariasis on the quality of life of people, with the disease in nine (9) communities in the Ahanta West District of the Western Region of Ghana where mass drug administration is being implemented for the past twenty years. Pearson's correlation, linear regression, and one-way analysis of variance (ANOVA) analyses were used to assess the associations between the LFSQQ instrument domains. RESULTS: Of the 155 study participants recruited, 115 (74.19%) were females, and 40 (25.81%) males. A greater proportion of the study participants (40, 25.8%) were presented with stage two (2) lymphoedema, while only two patients had stage seven (7) lymphoedema. The average of the overall quality of life scores of study participants was 68.24. There was a negative Pearson correlation (r = - 0.504, p-value < 0.001) between the stage of lymphoedema (severity of the disease) and the quality of life of the LF patients. In addition, a clear pattern of positive correlation (r = 0.71, p-value < 0.001) was observed between the disease burden and pain/discomfort domains of the study participants. Whereas the highest domain-specific score (85.03) was observed in the domain of self-care, we noted that the environmental domain, which consists of the financial status, was the lowest (45.94) among the study participants. CONCLUSION: Our findings support previous works on the reduced quality of life among lymphatic filariasispatients with pathology. In this study, our results reveal a depressing financial condition among people presenting with late stages of LF pathologies, which eventually reduces their well-being.
Entities:
Keywords:
Ghana; Lymphatic Filariasis; Quality of life
Authors: S K Dunyo; M Appawu; F K Nkrumah; A Baffoe-Wilmot; E M Pedersen; P E Simonsen Journal: Trans R Soc Trop Med Hyg Date: 1996 Nov-Dec Impact factor: 2.184
Authors: T G A N Chandrasena; R Premaratna; M A R V Muthugala; A Pathmeswaran; N R de Silva Journal: Trans R Soc Trop Med Hyg Date: 2006-11-13 Impact factor: 2.184
Authors: Michelle C Stanton; Masato Yamauchi; Square Z Mkwanda; Paul Ndhlovu; Dorothy Emmie Matipula; Charles Mackenzie; Louise A Kelly-Hope Journal: Infect Dis Poverty Date: 2017-04-03 Impact factor: 4.520
Authors: Sacha Horn; Manuel Ritter; Kathrin Arndts; Dennis Borrero-Wolff; Anna Wiszniewsky; Linda Batsa Debrah; Alexander Y Debrah; Jubin Osei-Mensah; Mkunde Chachage; Achim Hoerauf; Inge Kroidl; Laura E Layland Journal: Front Cell Infect Microbiol Date: 2022-01-06 Impact factor: 5.293